Type 2 Diabetes Mellitus study: Continuous glucose monitor vs Glucometer
Official title CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
ClinicalTrials.gov ID: NCT07184775
What this study is testing
- What it's testing
- The study wants to find out whether using a continuous glucose monitoring system improves how often pregnant women with type 2 diabetes record their blood sugar compared with traditional finger‑stick testing.
- Who it's for
- Pregnant women who have pre‑existing type 2 diabetes.
- What's involved
- Participants will be randomly assigned to either test their blood sugar with a finger‑stick glucometer four times a day or wear a sensor on their arm that measures sugar every few minutes and sends the data to a phone app. They will keep a log of the readings until delivery.
- Time commitment
- The study lasts from enrollment until the baby is born, with sensor changes every two weeks for the CGM group and regular finger‑stick testing for the other group.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- singleton pregnancies
- fetuses without anomalies
- diagnosis of Type 2 diabetes
- initiation of prenatal care at \<20 weeks gestation
You likely can't join if
- diagnosis of Type 1 diabetes
- allergy to insulin
- inability to wear a continuous glucose monitor
The study team makes the final eligibility decision.
Where it is enrolling
- Sewell, New Jersey, United States
- Philadelphia, Pennsylvania, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Sewell, New Jersey, United States; Philadelphia, Pennsylvania, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.